Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Bio-Techne Corp. | 9 | 0 | 0 | 0 | €64.50 | €75.80 | 17.519% |
Healthequity Inc. | 1 | 0 | 0 | 0 | €73.00 | €79.00 | 8.219% |
Charles River Labs Intl | 9 | 0 | 0 | 0 | €248.80 | €248.57 | -0.092% |
Veeva Systems A | 2 | 0 | 0 | 0 | €215.70 | - | - |
Lightpath Techs A | 3 | 0 | 0 | 0 | €1.26 | €2.78 | 120.921% |
Exelixis Inc. | 15 | 0 | 0 | 0 | €21.78 | €26.01 | 19.405% |
Vitrolife AB | 3 | 0 | 0 | 0 | €17.27 | - | - |
Anika Therapeutics | 4 | 0 | 1 | 0 | €23.40 | €26.58 | 13.596% |
Corcept Therapeutics Inc. | 7 | 0 | 1 | 0 | €23.80 | €31.72 | 33.257% |
Neurocrine Bioscience | 21 | 0 | 3 | 0 | €128.45 | €136.69 | 6.417% |
Community Health Systems Inc. | 3 | 3 | 0 | 0 | €3.10 | €5.65 | 82.245% |
AnaptysBio Inc | 5 | 2 | 1 | 0 | €19.50 | €46.24 | 137.128% |
Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €60.00 | - | - |
ShockWave Medical Inc | 1 | 0 | 0 | 0 | €300.90 | - | - |
X4 Pharmaceuticals, Inc. | 3 | 0 | 1 | 0 | €1.31 | €2.76 | 110.321% |
Viking Therapeutics Inc | 5 | 0 | 4 | 0 | €76.92 | €140.00 | 82.007% |
Sangamo Therapeutics Inc. | 11 | 11 | 2 | 0 | €0.57 | €2.79 | 389.642% |
Enanta Pharmaceuticals Inc. | 5 | 3 | 0 | 0 | €15.20 | €26.92 | 77.128% |
Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
Insmed Inc. | 10 | 1 | 0 | 0 | €23.60 | €45.11 | 91.137% |
Rigel Pharmaceutical Inc. | 9 | 0 | 3 | 0 | €1.36 | €13.74 | 908.602% |
Actinium Pharmaceuticals Inc. | 3 | 0 | 2 | 0 | €7.35 | €10.00 | 36.054% |
Tenet Healthcare | 20 | 0 | 1 | 0 | €97.00 | €92.71 | -4.423% |
Puma Biotechnology Inc. | 2 | 0 | 2 | 0 | €5.18 | €10.00 | 93.050% |
HCA Holdings Inc. | 17 | 0 | 1 | 0 | €306.80 | €295.60 | -3.652% |